PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Goette, Andreas
TI  - ARB Therapy in the Setting of Paroxysmal AF: Results from the ANTIPAF Trial
DP  - 2010 Dec 01
TA  - MD Conference Express
PG  - 16--16
VI  - 10
IP  - 8
4099  - http://mdc.sagepub.com/content/10/8/16.short
4100  - http://mdc.sagepub.com/content/10/8/16.full
AB  - Olmesartan does not reduce the incidence of atrial fibrillation (AF) episodes among patients with paroxysmal AF without structural heart disease, according to findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation [ANTIPAF; NCT0098137] trial.